LORBRENA vs NINTEDANIB

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. LORBRENA and NINTEDANIB are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LORBRENA	NINTEDANIB
Rating	64/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LORLATINIB	NINTEDANIB
Manufacturer	Pfizer	Teva Pharmaceuticals Development Inc
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	—	Idiopathic Pulmonary Fibrosis

lorbrena nintedanib

Rating

64/100

New

Pharmacy pays

—

Type

Active ingredient

LORLATINIB

NINTEDANIB

Manufacturer

Pfizer

Teva Pharmaceuticals Development Inc

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

—

Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Lorbrena and Nintedanib?

Lorbrena contains Lorlatinib, while Nintedanib contains Nintedanib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.